Search Results for: THERAPEUTIC FOCUS A New Patented
Articles
Cellectar Biosciences & Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates October 17, 2017
Cellectar Biosciences, Inc., an oncology-focused, clinical-stage biotechnology company, together with leading French pharmaceutical company Pierre Fabre, recently announced the extension...SPECIAL FEATURE - Injectable Drug Delivery: New Technologies Deliver Biologics & Differentiate Brands September 12, 2017
Contributor Cindy H. Dubin reports on a segment of the drug delivery industry that will see its market revenue double in just 5 years in response to a growing need to deliver highly viscous, high-volume drugs.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing: Biologics Present a New Set of Challenges May 2, 2016
Contributor Cindy H. Dubin speaks with leading syringe developers and contract manufacturers to discuss how they are overcoming industry challenges and provides a look at some of the innovative advancements in prefilled syringe technology.
Capsugel & Pulmatrix Enter Collaboration to Develop & Manufacture Novel Inhaled Therapeutics February 16, 2016
Capsugel and Pulmatrix, Inc. have recently formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The...Astellas Pharma & Immunomic Therapeutics Announce $300-Million Worldwide Partnership for LAMP-vax Products October 9, 2015
Immunomic Therapeutics, Inc. and Astellas Pharma Inc. recently announced they have entered into an exclusive worldwide license agreement to the...Cristal Therapeutics & PX Biosolutions to Develop Innovative Vaccines July 16, 2015
Cristal Therapeutics, a privately-held life sciences company developing innovative products against cancer and other diseases, by using its patented nanotechnology...ONL Therapeutics Provides Update on Novel Photoreceptor Protection Platform June 18, 2015
ONL Therapeutics, Inc. recently provided an update on the company’s ongoing drug development program to block the programmed cell death...BIND Therapeutics & Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin Nanoparticle Using Manocept Macrophage Targeting Platform June 11, 2015
BIND Therapeutics, Inc. and Macrophage Therapeutics recently announced they have entered into a research collaboration to engineer Accurins with the...Access Pharmaceuticals Announces Global Plasma Therapeutics License September 30, 2014
Access Pharmaceuticals has signed an exclusive global license agreement with Plasma Technologies LLC for the development and commercialization of its...ADVANCED DELIVERY DEVICES - New Drug Delivery & Stabilization Platforms Gaining Global Interest March 5, 2014
Sam de Costa, PhD, believes the launch of two stabilization and drug delivery platforms that have the potential to revolutionize the delivery of vaccines, therapeutics, and diagnostics, while significantly cutting costs, has attracted sharp interest from pharmaceutical and biotech companies around the world.
SPECIAL FEATURE - Hand Held Devices: New Technologies Right the Wrongs of Earlier Devices October 4, 2013
Contributor Cindy H. Dubin highlights in this annual report that new devices are coming to market that not only address the trends of home care and a need for delivering larger doses, but are also cleaning up the spotty reputation of early stage devices.
TRANSDERMAL DELIVERY - New Frontiers in Transdermal Drug Delivery April 30, 2013
Kenneth B. Kirby and Chandan A.S. Alam, MD, are part of a team at Transdermal Delivery Solutions Corp. (TDSC) that has been leveraging its patented technology to develop a unique patchless, metered pump, spray-on drug delivery system and products.
BioTime Signs Agreements With Jade Therapeutics July 19, 2012
BioTime, Inc. recently announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a...Ei Increases Capabilities Through New Partnership April 15, 2012
Ei, A Pharmaceutical SolutionWorks, recently announced a new partnership with KeraNetics. Ei has begun a $13.2-million expansion within their recently...NanoSmart Begins Development of New Drug Delivery Platform for Cancer September 18, 2011
NanoSmart Pharmaceuticals, Inc., a biopharmaceutical corporation developing novel cancer pharmaceuticals, has moved into its new corporate facility located in Laguna...Pluri Launches Novel Immunotherapy Platform for Solid Tumor Treatment May 2, 2024
Pluri Inc. recently launched its placental allogeneic MAIT cell platform for immunotherapy treatment for solid tumors – a significant medical...TFF Pharmaceuticals Makes Available Phase 2 Data From Tacrolimus Inhalation Powder for the Prevention of Lung Transplant Rejection April 29, 2024
TFF Pharmaceuticals, Inc. recently announced data from the company’s ongoing Phase 2 trial of Tacrolimus Inhalation Powder (TFF TAC) for...ProMed Pharma Acquires SpineThera Manufacturing Capabilities & Option to License Intellectual Property April 4, 2024
ProMed Pharma LLC and SpineThera, Inc. recently announced ProMed Pharma has acquired SpineThera’s cGMP manufacturing operational assets. ProMed Pharma also obtained an option to….